Life Spine Gains FDA Clearance for LONGBOW Titanium Spacer

By Julie A. Vetalice

Life Spine was granted FDA 510(k) clearance to market the LONGBOW® Titanium Lateral Expandable Spacer, an update to the original LONGBOW that was launched in 2016.

LONGBOW is available in lengths from 45mm to 60mm, heights from 9mm to 15mm, 0° and 7° lordotic options and widths that expand from 15mm to 27mm anterior to posterior. LONGBOW can be post-packed after expansion in situ with up to 11cc of graft and features OSSEO-LOC™ Surface Technology to promote bony on-growth. LONGBOW is complemented by Life Spine’s lateral solutions such as the CENTRIC® Plier Style Retractor, Lateral Disc Prep Instruments, and SENTRY™ Lateral Plating.

“We are thrilled to be releasing a Titanium version of the first to market LONGBOW Expandable Lateral Spacer System which was designed to accomplish previously unmet surgical goals,” said Rich Mueller, Chief Operating Officer for Life Spine. “The spacer is able to achieve up to 12mm of anterior to posterior expansion allowing for a contracted insertion size of 15mm, but once expanded can boast a footprint closer to that of an ALIF spacer as opposed to a traditional lateral spacer.”

Product Labels: Spinal Fusion

Tags: 510(k) Clearance, Regulatory